Approximately 50% of patients with F-HSCR carry a variant in the RET gene, which is also the causative gene of multiple endocrine neoplasia type 2 (MEN2; OMIM #171300) [1-4]. This evidence concerns the gene RET and multiple endocrine neoplasia type 2.